Understanding the Impact of Respiratory Viral Infections on Immunocompromised Populations
DOI:
https://doi.org/10.58445/rars.1354Abstract
Respiratory viral infections like COVID-19, influenza, and respiratory syncytial viruses impact human health tremendously, especially that of immunocompromised people. These individuals have a weakened immune system and, thus, are more vulnerable to catching and developing worse infections. This report contrasts the normal immune response to respiratory infections with the response and impact of viral disease on the immunocompromised. Specifically, it will focus on individuals with autoimmune diseases (systemic lupus erythematosus), chronic diseases that affect the immune system (lymphoma and persistent Epstein-Barr virus infection), and people who fall into high-risk age categories (adults greater than age 65 and infants from 0 to 6 months). The goal is to explore the effects of respiratory viral disease on groups with weakened immunity to identify protective strategies for them in our communities. We propose vaccination and healthcare accessibility as well as strict adherence to public health guidelines and personal preventative measures, as important ways to safeguard our vulnerable population.
References
References
Respiratory Syncytial Virus (RSV) – NFID. https://www.nfid.org/infectious-disease/rsv/.
Definition of immunocompromised - NCI Dictionary of Cancer Terms - NCI. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/immunocompromised (2011).
What Does It Mean To Be ‘Immunocompromised’? Yale Medicine https://www.yalemedicine.org/news/what-does-immunocompromised-mean.
Respiratory Viruses and People with Weakened Immune Systems | Respiratory Illnesses | CDC. https://www.cdc.gov/respiratory-viruses/risk-factors/weakened-immune-systems.html (2024).
Respiratory Viruses and Older Adults | Respiratory Illnesses | CDC. https://www.cdc.gov/respiratory-viruses/risk-factors/older-adults.html (2024).
CDC. Learn about RSV in older adults with chronic medical conditions. Centers for Disease Control and Prevention https://www.cdc.gov/rsv/high-risk/older-adults.html (2024).
U.S. - seniors as a percentage of the population 2022. Statista https://www.statista.com/statistics/457822/share-of-old-age-population-in-the-total-us-population/.
Australia, H. What is the difference between bacterial and viral infections? https://www.healthdirect.gov.au/bacterial-vs-viral-infection (2023).
Upper Respiratory Infection: Symptoms, Contagious, Treatment. Cleveland Clinic https://my.clevelandclinic.org/health/articles/4022-upper-respiratory-infection.
Ryu, W.-S. Virus Life Cycle. Mol. Virol. Hum. Pathog. Viruses 31–45 (2017) doi:10.1016/B978-0-12-800838-6.00003-5.
You Are Immune Against Every Disease. (2021).
Mueller, S. N. & Rouse, B. T. Immune responses to viruses. Clin. Immunol. 421–431 (2008) doi:10.1016/B978-0-323-04404-2.10027-2.
Aristizábal, B. & González, Á. Innate immune system. in Autoimmunity: From Bench to Bedside [Internet] (El Rosario University Press, 2013).
Weakened Immune System - Penn Medicine. https://www.pennmedicine.org/updates/blogs/health-and-wellness/2020/march/weakened-immune-system.
General Principles of COVID-19 Vaccines for Immunocompromised Patients - Hematology.org. https://www.hematology.org/covid-19/covid-19-and-vaccines.
Martins, K. Autoimmune Diseases. WebMD https://www.webmd.com/a-to-z-guides/autoimmune-diseases.
Smatti, M. K. et al. Viruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms. Viruses 11, 762 (2019).
Sundaresan, B., Shirafkan, F., Ripperger, K. & Rattay, K. The Role of Viral Infections in the Onset of Autoimmune Diseases. Viruses 15, 782 (2023).
Rojas, M. et al. Molecular mimicry and autoimmunity. J. Autoimmun. 95, 100–123 (2018).
Lupus-Lupus - Symptoms & causes. Mayo Clinic https://www.mayoclinic.org/diseases-conditions/lupus/symptoms-causes/syc-20365789.
Joo, Y. B., Kim, K.-J., Park, K.-S. & Park, Y.-J. Influenza infection as a trigger for systemic lupus erythematosus flares resulting in hospitalization. Sci. Rep. 11, 4630 (2021).
Ramachandran, L., Dontaraju, V. S., Troyer, J. & Sahota, J. New onset systemic lupus erythematosus after COVID-19 infection: a case report. AME Case Rep. 6, 14 (2022).
Hodgkin’s lymphoma (Hodgkin’s disease) - Symptoms and causes. Mayo Clinic https://www.mayoclinic.org/diseases-conditions/hodgkins-lymphoma/symptoms-causes/syc-20352646.
Definition of hematologic cancer - NCI Dictionary of Cancer Terms - NCI. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hematologic-cancer (2011).
(PDF) Management of Respiratory Viral Infections in Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies. https://www.researchgate.net/publication/267741702_Management_of_Respiratory_Viral_Infections_in_Hematopoietic_Cell_Transplant_Recipients_and_Patients_With_Hematologic_Malignancies.
Epstein-Barr and Infectious Mononucleosis (Mono) | CDC. https://www.cdc.gov/epstein-barr/index.html (2024).
Chen, C.-L. et al. The Role of Epstein-Barr Virus in Adults With Bronchiectasis: A Prospective Cohort Study. Open Forum Infect. Dis. 7, ofaa235 (2020).
Shannon-Lowe, C., Rickinson, A. B. & Bell, A. I. Epstein–Barr virus-associated lymphomas. Philos. Trans. R. Soc. B Biol. Sci. 372, 20160271 (2017).
How COVID-19 affects babies and children. Mayo Clinic https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/coronavirus-in-babies-and-children/art-20484405.
Fauroux, B. et al. The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood. Infect. Dis. Ther. 6, 173–197 (2017).
Ponnappan, S. & Ponnappan, U. Aging and Immune Function: Molecular Mechanisms to Interventions. Antioxid. Redox Signal. 14, 1551–1585 (2011).
Flu and Older Adults - NFID. https://www.nfid.org/ https://www.nfid.org/infectious-diseases/flu-and-older-adults/.
What Do We Know About Long COVID? National Institute on Aging https://www.nia.nih.gov/health/covid-19/what-do-we-know-about-long-covid.
Avery, R. K. Immunizations in adult immunocompromised patients: Which to use and which to avoid. Cleve. Clin. J. Med. 68, 337–348 (2001).
Patel, P. Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023. MMWR Morb. Mortal. Wkly. Rep. 72, (2023).
Mortiboy, M. et al. Combating COVID-19 Vaccine Inequity During the Early Stages of the COVID-19 Pandemic. J. Racial Ethn. Health Disparities 1–10 (2023) doi:10.1007/s40615-023-01546-0.
Pollard, A. J. & Bijker, E. M. A guide to vaccinology: from basic principles to new developments. Nat. Rev. Immunol. 21, 83–100 (2021).
Products - Data Briefs - Number 452 - November 2022. https://www.cdc.gov/nchs/products/databriefs/db452.htm (2022) doi:10.15620/cdc:121837.
Taylor, C. A. (2023). COVID-19–Associated Hospitalizations Among U.S. Adults Aged ≥65 Years — COVID-NET, 13 States, January–August 2023. MMWR. Morbidity and Mortality Weekly Report, 72. https://doi.org/10.15585/mmwr.mm7240a3
Downloads
Posted
Categories
License
Copyright (c) 2024 Siqi Lai, Kim-Marie A. Dam
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.